| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ccd25cf2e8d9d4135ca70051591a1e4 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 |
| filingDate |
2011-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47e7d49432c7e3a39a5595a256e7d4d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a05a9ecdfa5572521bcd0e5e87852d4b |
| publicationDate |
2013-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-I406668-B |
| titleOfInvention |
Medicinal composition for inhibiting growth of Helicobacter pylori and inhibiting inflammatory reaction of Helicobacter pylori-induced gastric epithelial cells |
| abstract |
The present invention relates to a pharmaceutical composition for inhibiting Helicobacter pylori and H. pylori-induced inflammatory responses in gastric epithelial cells, which contains ovatodiolide compound and a pharmaceutically acceptable carrier. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2990050-A1 |
| priorityDate |
2011-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |